Adma Biologics Inc. (ADMA)
NASDAQ · Healthcare
Adma Biologics Inc. annual/quarterly long term debt history from 2016 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Adma Biologics Inc. long term debt for the quarter ending December 31, 2025 were 72.1M, a 0.27% decrease year-over-year.
- Adma Biologics Inc. long term debt for 2025 were 72.1M, a 0.27% decrease from 2024.
- Adma Biologics Inc. long term debt for 2024 were 72.3M, a 2520.91% increase from 2018.
- Adma Biologics Inc. long term debt for 2018 were 2.8M, a 0.00% increase from 2017.
- Adma Biologics Inc. long term debt for 2017 were 2.8M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Adma Biologics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $72 |
| 2024 | $72 |
| 2018 | $3 |
| 2017 | $3 |
| 2016 | $2 |
| Adma Biologics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $72 |
| 2024-12-31 | $72 |
| 2018-12-31 | $3 |
| 2017-12-31 | $3 |
| 2016-12-31 | $2 |
Adma Biologics Inc. Long Term Debt — FAQ
Adma Biologics Inc. (ADMA) long term debt over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ADMA's long term debt history?
The chart and table above show Adma Biologics Inc.'s long term debt by year and by quarter, including the growth rate.